2018
DOI: 10.1055/s-0037-1609935
|View full text |Cite
|
Sign up to set email alerts
|

Syntheses of Ketamine and Related Analogues: A Mini Review

Abstract: Ketamine [2-(2-chlorophenyl)-2-(methylamino)cyclohexanone] is a dissociative anaesthetic, first developed in 1963 by Parke-Davis. It finds widespread application in the treatment of battlefield injuries, and in emergency departments for use in children. In recent times the clinical interest in ketamine has increased due to the positive impact it has in treating depression and the rapid onset of its antidepressant effect. This review covers the synthetic effort towards ketamine and related analogues over the pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 52 publications
0
5
0
Order By: Relevance
“…Subsequently, 2‐CPNCH was reacted with zinc powder and acetic acid to form norketamine. Through N ‐methylation of norketamine by using formaldehyde and sodium cyanoborohydride, ketamine was obtained [10, 11]. In addition, Yen et al.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…Subsequently, 2‐CPNCH was reacted with zinc powder and acetic acid to form norketamine. Through N ‐methylation of norketamine by using formaldehyde and sodium cyanoborohydride, ketamine was obtained [10, 11]. In addition, Yen et al.…”
Section: Introductionmentioning
confidence: 99%
“…The synthesis of ketamine has been studied for the purposes of medicine use or against illicit drug manufacturing [6][7][8][9][10][11][12][13][14][15][16]. In real life, two processes for syntheses of ketamine as indicated in Figure 1A,B were commonly found in illicit ketamine manufacturing units [6][7][8][9][10][11][12][13].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…12,13 Stimulated by the stronger potency of (S)-ketamine for the NMDA receptor, many asymmetric synthetic routes have been reported over the years. 14 For example, the first asymmetric synthetic process of (S)-ketamine was reported by Kiyooka and colleagues. 15 The innovative procedure was conducted in 10 steps and (S)-ketamine was obtained in 21% yield (97% ee).…”
Section: ■ Introductionmentioning
confidence: 99%